Scientific inferences in the laboratory and the law

American Journal of Public Health

Volumn 95, Issue SUPPL. 1, 2005, Pages

  Cranor, Carl ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL COMPOUND;

COURT; DECISION MAKING; EXPERT SYSTEM; JUSTICE; LABORATORY; LAW; PUBLIC HEALTH; REVIEW; SCIENCE; TOXICITY;

ENVIRONMENTAL EXPOSURE; EXPERT TESTIMONY; FORENSIC SCIENCES; GOVERNMENT REGULATION; HUMANS; JUDICIAL ROLE; LIABILITY, LEGAL; PUBLIC HEALTH; PUBLIC POLICY; RISK ASSESSMENT; SCIENCE; SUPREME COURT DECISIONS; UNITED STATES;

EID: 22744451771     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2004.044735     Document Type: Review

References (74)

1. Daubert v Merell Dow Pharmaceuticals, Inc, 509 US 579 (1993).
2. General Electric Co v Joiner, 522 US 136 (1997).
3. Kumho Tire Co v Carmichael, 526 US 137 (1999).
4. Cranor CF, Eastmond DA. Scientific ignorance and reliable patterns of evidence in toxic tort causation: Is there a need for liability reform? Law Contemp Prob. 2001;64:5-48.
5. Cranor CF. Justice, inference to the best explanation and the judicial evaluation of scientific evidence. In: Campbell JK, O'Rourke M, Shier D, eds. Topics in Contemporary Philosophy, Vol. III: Law and Social Justice. Cambridge, Mass: MIT Press; 2005.
6. Thagard P. How Scientists Explain Disease. Princeton, NJ: Princeton University Press; 1999.
7. Federal Rules of Evidence, Rule 401. 2001.
8. Wright L. Critical Thinking: An Introduction to Analytical Reasoning and Reading. New York, NY: Oxford University Press; 2001.
9. Kramer MS, Lane DA. Causal propositions in clinical research and practice. J Clin Epidemiol. 1992;45: 639-649.
10. Hutchinson IA, Lane DA. Standardized methods of causality assessment for suspected adverse drug reactions. J Chronic Dis. 1989;39:857-890.
11. Hutchinson TA, Lane DA. Assessing methods for causality assessment of suspected adverse drug reactions. J Clin Epidemiol. 1989;42:5-16.
12. Haack S. An epistemologist in the bramblebush: at the Supreme Court with Mr. Joiner. J Health Polit Policy Law. 2001;26:217-237.
13. In re Agent Orange, 611 F Supp 1223 (ED, New York, 1985).
14. Viterbo v Dow Chemical Co, 826 F2d 420, 5th Cir 1987.
15. Lynch v Merrell Nat. Lab., 830 F2d 1190, 1st Cir 1987.
16. Brock v Merrell Dow Pharmaceuticals, Inc, 874 F2d 307, 5th Cir 1989.
17. Turpin v Merrell Dow Pharmaceuticals, Inc, 959 F2d 1349, 6th Cir 1992.
18. Allen v Pennsylvania Engineering Corp, 102 F3d 194, 5th Cir 1996.
19. Rall DP, Hogan MD, Huff JE, Schwetz BA, Tennant RW. Alternatives to using human experience in assessing health risks. Ann Rev Public Health. 1987;8: 355-385.
20. Huff J, Rall DP. Relevance to humans of carcinogenesis results from laboratory animal toxicology studies. In: Last JM, Wallace RB, eds. Maxcy-Rosenau-Last Public Health and Preventive Medicine. 13th ed. Norwalk, Conn: Appleton & Lange; 1992:433-452.
21. Gray GM, Li P, Shlyakhter I, Wilson R. An empirical examination of factors influencing prediction of carcinogenic hazard across species. Reg Toxicol Pharmacol. 1995;22:283-291.
22. US Environmental Protection Agency. Proposed guidelines for carcinogen risk assessment. Fed Regist. 1996;61(79)17960-18011.
23. Huff J. Chemicals and cancer in humans: First evidence in experimental animals. Environ Health Persp. 1993;100:201-210.
24. Pest control: an assessment of present and alternative technologies. In: Contemporary Pest Control Practices and Prospects: The Report of the Executive Committee. Washington, DC: National Research Council; 1975.
25. Fung VA, Barrett CJ, Huff J. The carcinogenesis bioassay in perspective: Application in identifying human cancer hazards. Environ Health Persp. 1995; 103:680-683.
26. Tomatis L, Huff J, Hertz-Picciotto I, et al. Avoided and avoidable risks of cancer. Carcinogenesis 1997;8: 97-105.
27. In re Paoli R.R. Yard PCB Litig, 35 F3d 717-799, 3rd Cir 1994, cert. denied, 513 US 1190; 1994.
28. Cranor CF, Strauss DJ. Case Studies in Law and Science. Forthcoming.
29. Casey v Ohio Medical Products, 877 F Supp 1380 At 1385 (ND, California 1995)
30. Stratton ER, Howe CJ, Johnston RB, eds. Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academy Press; 1994.
31. Collet J-P, MacDonald N, Cashman N, Pless R, and Advisory Committee on Causality Assessment. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Bull World Health Organ. 2000;78:178-185.
32. International Agency for Research on Cancer. Preamble to the IARC Monograph Series (8. Studies of Cancer in Humans). Available at: http://www-cie.iarc. fr/monoeval/studieshumans.html. Accessed March 15, 2005.
33. Harman G. The inference to the best explanation. Philos Rev. 1964;LXXIV:89-90.
34. Hill AB. The environment and disease: Association or causation? Proc R Soc Med. 1965;58:295-300.
35. Reprinted in: Greenland S, ed. Evolution of Epidemiologic Ideas: Annotated Readings on Concepts and Methods. Chestnut Hill, MA; 1987:15-19.
36. Cullen MR, Rosenstock L, Brooks SM. Clinical approach and establishing a diagnosis of an environmental medical disorder. In: Brooks SM, Gochfeld M, Herzstein J, Jackson RJ, Schenker MB, eds. Environmental Medicine. St Louis, Mo: Mosby; 1995:217-231.
37. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1996.
38. Wright L. Practical Reasoning. New York, NY: Harcourt Brace Jovanovich; 1989.
39. Electric and magnetic fields risk evaluation guidelines. Sacramento: California Department of Health Services; 1999.
40. Black v Food Lion, Inc. 171 F3d 308, 5th Or 1999.
41. Westberry v Gislaved Gummi, 178 F3d 257, 4th Cir 1999.
42. Hollander v Sandoz Pharmaceuticals Corp, 95 F Supp 2d 1230-1239 (WD, Oklahoma, 2000).
43. Santone KS, Powis G. Mechanism of and tests for injuries. In: Hayes WJ Jr, Laws ER Jr, eds. Handbook of Pesticide Toxicology. New York, NY: Academic Press; 1991:169-214.
44. Green MD. Legal Theory: Expert witnesses and sufficiency of evidence in toxic substances litigation. NWU Law Rev. 1992;86:643-699.
45. Green MD. Bendectin and birth defects. Philadelphia: University of Pennsylvania Press; 1996.
46. Glastetter v Novartis Pharmaceuticals Corp, 107 F Supp 2d 1015-1046 (ED, Missouri, 2000).
47. Cranor CF. Regulating Toxic Substances. New York, NY: Oxford University Press; 1993.
48. Cranor CF, Fischer JG, Eastmond DA. Judicial boundary-drawing and the need for context-sensitive science in toxic torts after Daubert v Merrell-Dow Pharmaceuticals. Va Environ Law J. 1996;16:1-77.
49. Rinsky RA, Hornung RW, Silver SR, Tseng CY. Benzene exposure and hematopoietic mortality: A long-term epidemiological risk assessment. Am J Indus Med. 2002;42:474-480.
50. Silver SR, Rinsky RA, Cooper SP, Hornung RW, Lai D. Effect of follow-up time on risk estimates: Longitudinal examination of the relative risks of leukemia and multiple myeloma in a rubber hydrochloride cohort. Am J Indus Med. 2002;42:481-489.
51. Weed DL. [National Cancer Institute.] Personal Communication; January 2003.
52. Weed DL. Underdetermination and incommensurability in contemporary epidemiology. Kennedy Inst Ethics J. 1997;7:107-114.
53. Correspondence from Jerry M. Rice to Vicent DelPizzo of the California Electric and Magnetic Fields Program. Sent to the author February 1, 2003.
54. International Agency for Research on Cancer. IARC Monograph Series, Vol. 57, 4,4′-METHYLENEBIS(2-CHLOROANILINE) (MOCA). Available at: http://www-cie.iarc fr/htdocs/monographs/vol57/15-moca.html. Accessed March 15, 2005.
55. International Agency for Research on Cancer, IARC Monograph Series, Supplement 7, Chloroethylnitrosoureas. Available at: http://www-cie.iarc.fr/ htdocs/monographs/suppl7/chloroethylnitrosoureas.html. Accessed March 15, 2005.
56. Gregus Z, Klaassen CD. Mechanisms of toxicity. In: Klaassen CD, ed. Casarett and Doull's Toxicology. 6th ed. New York, NY: McGraw-Hill; 2001:35-82.
57. Preston RJ, Hoffman GR. Genetic toxicology. In: Klaassen CD, ed. Casarett and Doull's Toxicology. 6th ed. New York, NY: McGraw-Hill; 2001:321-350.
58. Public Health Service, National Toxicology Program. 10th Annual Report on Carcinogens. Washington, DC: US Department of Health and Human Services; December 2002.
59. International Agency for Research on Cancer. Probably carcinogenic to humans, Benzidine-based dyes. Available at: http://www-cie.iarc.fr/htdocs/ monographs/suppl7/benzidinedyes.html. Accessed March 15, 2005
60. International Agency for Research on Cancer. Overall evaluations of carcinogenicity to humans: Group 2A: probably carcinogenic to humans. Available at: http://www-cie.iarc.fr/monoeval/crthgr02a.html. Accessed March 15, 2005.
61. Klatskin G, Kimberg DV. Recurrent hepatitis attributable to halothane sensitization in an anesthetist. N Engl J Med. 1969;280:515-522.
62. Mill JS. A System of Logic: Ratiocinative and Inductive. London, England: Longmany, Green & Co; 1941.
63. Falk H, Creech JL Jr, Heath CW Jr, Johnson MN, Key MM. Hepatic disease among workers at a vinyl chloride polymerization plant. JAMA. 1974;230: 59-68.
64. Huff J, Melnick R. Chemical carcinogenesis bioassays: Critical for the sensible application of the precautionary principle for protecting public health. Presentation to Collegium Ramazzini, October 23-24, 2002.
65. Identifying and Regulating Carcinogens. Washington, DC: Office of Technology Assessment, US Congress; 1987.
66. Huff J, Hoel D. Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assessment for cancer and human health. Scand J Work Environ Health. 1992;18:83-89.
67. National Academy of Sciences. Toxicity Testing: Strategies to Determine Needs and Priorities. Washington, DC: National Academy Press; 1984.
68. Bailor JC, Bingham E. Personal communications at Collegium Ramazzini, 2002.
69. EPA, EDF, CMA agree on testing program targeting 2,800 chemicals. Environ Health Letter. October 1998;37:193.
70. Screening and Testing Chemicals in Commerce. Washington, DC: Office of Technology Assessment, US Congress; 1995.
71. Berger MA. Eliminating general causation: Notes toward a new theory of justice and toxic torts. Colum Law Rev. 1997;97:2117-2151.
72. Rawls J. Political Liberalism. Cambridge, Mass: Harvard University Press; 1993.
73. Assessment of Health Effect from Exposure to Power-Line Frequency Electric and Magnetic Fields. Research Triangle Park, NC: National Institute of Environmental Health Sciences; 1998.
74. Neutra RR, DelPizzo V, Lee G. An evaluation of the possible risks from electric and magnetic fields (EMFs) from power lines, internal wiring, electrical occupations, and appliances. Final Report, Sacramento: California Department of Health Services; 2002.